794
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Urine neutrophil gelatinase-associated lipocalin in septic patients with and without acute kidney injury

, , &
Pages 1399-1403 | Received 04 Apr 2014, Accepted 10 Jul 2014, Published online: 04 Aug 2014

References

  • Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA. 2005;294(7):813–818
  • Neveu H, Kleinknecht D, Brivet F, et al. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French study Group on Acute Renal Failure. Nephrol Dial Transplant. 1996;11(2):293–299
  • Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med. 2001;29(10):1910–1915
  • Bagshaw SM, Laupland KB, Doig CJ, et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: A population-based study. Crit Care. 2005;9(6):R700–R709
  • Bagshaw SM, Uchino S, Bellomo R, et al. Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007;2(3):431–439
  • Oppert M, Engel C, Brunkhorst FM, et al. Acute renal failure in patients with severe sepsis and septic shock—A significant independent risk factor for mortality: Results from the German Prevalence Study. Nephrol Dial Transplant. 2008;23(3):904–909
  • Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: A multicentre evaluation. Crit Care. 2008;12(2):R47
  • Ishikawa K, May CN, Gobe G, et al. Pathophysiology of septic acute kidney injury: A different view of tubular injury. Contrib Nephrol. 2010;165:18–27
  • Wan L, Bagshaw SM, Langenberg C, et al. Pathophysiology of septic acute kidney injury: What do we really know? Crit Care Med. 2008;36(4 Suppl):S198–S203
  • Abraham BP, Frazier EA, Morrow WR, et al. Cystatin C and neutrophil gelatinase-associated lipocalin as markers of renal function in pediatric heart transplant recipients. Pediatr Transplant. 2011;15(6):564–569
  • Kim H, Hur M, Cruz DN, et al. Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis. Clin Biochem. 2013;46(15):1414–1418
  • Wheeler DS, Devarajan P, Ma Q, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med. 2008;36(4):1297–1303
  • Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530–538
  • Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure—Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–R212
  • Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Crit Care Med. 1985;13(10):818–829
  • Xu SY, Petersson CG, Carlson M, et al. The development of an assay for human neutrophil lipocalin (HNL)-to be used as a specific marker of neutrophil activity in vivo and vitro. J Immunol Methods. 1994;171:245–252
  • Clark WR, Letteri JJ, Uchino S, et al. Recent clinical advances in the magagement of critically ill patients with acute renal failure. Blood Purif. 2006;24(5–6):487–498
  • Baqshaw SM, Bennett M, Devarajan P, et al. Urine biochemistry in septic and non-septic acute kidney injury: A prospective observational study. J Crit Care. 2013;28(4):371–378
  • Guo Y, Yan KP. Prognostic significance of urine neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury. Exp Ther Med. 2011;2(6):1133–1139
  • Martensson J, Bell M, Oldner A, et al. Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med. 2010;36(8):1333–1340
  • Aydogdu M, Gürsel G, Sancak B, et al. The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and cystatin C in early diagnosis of septic acute kidney injury in critically ill patients. Dis Markers. 2013;34(4):237–246
  • Zappitelli M, Washburn KK, Arikan AA, et al. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: A prospective cohort study. Crit Care. 2007;11(4):R84
  • De Geus HR, Woo JG, Wang Y, et al. Urinary neutrophil gelatinase-associated lipocalin measured on admission to the intensive care unit accurately discriminates between sustained and transient acute kidney injury in adult critically ill patients. Nephron Extra. 2011;1(1):9–23
  • Smertka M, Wroblewska J, Suchojad A, et al. Serum and urinary NGAL in septic newborns. Biomed Res Int. 2014;2014:717318
  • Baqshaw SM, Bennett M, Haase M, et al. Plasma and urine neutrophil gelatinaseassociated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2010;36(3):452–461
  • Liu KD, Himmelfarb J, Paganini E, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1(5):915–919

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.